Liver Adverse Outcome Pathways: What's in for the Hepatologist?

Area of Science:

• Toxicology
• Chemical Risk Assessment
• Hepatology
• Clinical Research

Background:

• Adverse outcome pathways (AOPs) are established tools for visualizing mechanisms of toxicity.
• Current applications of AOPs are primarily in toxicology and chemical risk assessment.
• Clinical applications of AOPs, especially in hepatology, remain underexplored.

Purpose of the Study:

• To explore the potential clinical applications of liver adverse outcome pathways (LAOPs).
• To highlight the utility of LAOPs in developing and optimizing animal models for liver diseases.
• To discuss the role of LAOPs in identifying novel diagnostic and prognostic biomarkers for liver conditions.

Main Methods:

• Literature review and conceptual analysis of AOPs in the context of hepatology.
• Identification of potential applications in preclinical research and clinical diagnostics.
• Discussion of requirements for clinical translation.

Main Results:

• Liver AOPs can significantly aid in the development and refinement of clinically relevant animal models for liver diseases.
• LAOPs can facilitate the discovery and characterization of specific biomarkers for liver disease diagnosis and prognosis.
• The full clinical potential of LAOPs requires further technical development and interdisciplinary collaboration.

Conclusions:

• Liver AOPs offer promising avenues for advancing liver disease research and clinical practice.
• Optimization of AOPs and collaborative efforts are crucial for their successful clinical implementation.
• AOPs represent a valuable framework for integrating mechanistic understanding into clinical hepatology.